The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online December 11, 2009
The Journal of Immunology, 2010, 184, 965 -974
Copyright © 2010 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0902840

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0902840v1
184/2/965    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansdottir, S.
Right arrow Articles by Hunninghake, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansdottir, S.
Right arrow Articles by Hunninghake, G. W.

Vitamin D Decreases Respiratory Syncytial Virus Induction of NF-{kappa}B–Linked Chemokines and Cytokines in Airway Epithelium While Maintaining the Antiviral State

Sif Hansdottir, Martha M. Monick, Nina Lovan, Linda Powers, Alicia Gerke, and Gary W. Hunninghake

Department of Medicine, University of Iowa Carver College of Medicine and Veterans Administration Medical Center, Iowa City, IA 52242

Epidemiological studies suggest that low vitamin D levels may increase the risk or severity of respiratory viral infections. In this study, we examined the effect of vitamin D on respiratory syncytial virus (RSV)-infected human airway epithelial cells. Airway epithelium converts 25-hydroxyvitamin D3 (storage form) to 1,25-dihydroxyvitamin D3 (active form). Active vitamin D, generated locally in tissues, is important for the nonskeletal actions of vitamin D, including its effects on immune responses. We found that vitamin D induces I{kappa}B{alpha}, an NF-{kappa}B inhibitor, in airway epithelium and decreases RSV induction of NF-{kappa}B–driven genes such as IFN-β and CXCL10. We also found that exposing airway epithelial cells to vitamin D reduced induction of IFN-stimulated proteins with important antiviral activity (e.g., myxovirus resistance A and IFN-stimulated protein of 15 kDa). In contrast to RSV-induced gene expression, vitamin D had no effect on IFN signaling, and isolated IFN induced gene expression. Inhibiting NF-{kappa}B with an adenovirus vector that expressed a nondegradable form of I{kappa}B{alpha} mimicked the effects of vitamin D. When the vitamin D receptor was silenced with small interfering RNA, the vitamin D effects were abolished. Most importantly we found that, despite inducing I{kappa}B{alpha} and dampening chemokines and IFN-β, there was no increase in viral mRNA or protein or in viral replication. We conclude that vitamin D decreases the inflammatory response to viral infections in airway epithelium without jeopardizing viral clearance. This suggests that adequate vitamin D levels would contribute to reduced inflammation and less severe disease in RSV-infected individuals.

Address correspondence and reprint requests to Dr. Sif Hansdottir, University of Iowa Hospitals and Clinics, Division of Pulmonary and Critical Care, 200 Hawkins Drive, C323GH, Iowa City, IA 52242-1081. E-mail address: sif-hansdottir{at}uiowa.edu

This work was supported by National Institutes of Health Grants KL2 RR024980, R01 HL079901, R01 HL077431, R01 HL073967, and T32 HL007638 and a Veterans Administration Merit Review grant.

Abbreviations used in this paper:

1,25D, 1,25-dihydroxyvitamin D3; hTBE, human tracheobronchial epithelial; IRF, IFN regulatory factor; ISG, IFN-stimulated gene; ISG15, IFN-stimulated protein of 15 kDa; ISRE, IFN-stimulated response element; MOI, multiplicity of infection; MxA, myxovirus resistance A; QRT-PCR, quantitative real-time PCR; RSV, respiratory syncytial virus; siRNA, small interfering RNA; VDR, vitamin D receptor.


Related articles in The JI:

IN THIS ISSUE

The JI 2010 184: 533-534. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. Urashima, T. Segawa, M. Okazaki, M. Kurihara, Y. Wada, and H. Ida
Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren
Am. J. Clinical Nutrition, May 1, 2010; 91(5): 1255 - 1260.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved.